Payment overview · 2025
General Payments
$23.11
1 reported records · 1 companies
Healthcare provider profile · identity verified
Myra A Young, NP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MUSKOGEE, OK · NPI 1730544305
Verified facts
What the public records show
CMS Open Payments records show Myra A Young, NP received $23.11 in general payments during 2025 across 1 reported records.
Braeburn Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Braeburn Inc. | Unresolved — no canonical attribution shown | $23.11 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.11 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $23.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 400 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 354 | 32 |
| Atorvastatin Calcium | Atorvastatin Calcium | 345 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 302 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 286 | 26 |
| Levothyroxine Sodium | Levothyroxine Sodium | 284 | 26 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 272 | 24 |
| Amlodipine Besylate | Amlodipine Besylate | 261 | 25 |
| Gabapentin | Gabapentin | 210 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 177 | 18 |
| Eliquis | Apixaban | 171 | 15 |
| Jardiance | Empagliflozin | 153 | 15 |
| Potassium Chloride | Potassium Chloride | 150 | 18 |
| Furosemide | Furosemide | 148 | 19 |
| Trazodone Hcl | Trazodone Hcl | 148 | 16 |
| Sertraline Hcl | Sertraline Hcl | 145 | 17 |
| Pregabalin | Pregabalin | 141 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 125 | 13 |
| Metformin Hcl | Metformin Hcl | 119 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 118 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 12 |
| Lidocaine | Lidocaine | 103 | 20 |
| Buspirone Hcl | Buspirone Hcl | 98 | 13 |
| Losartan Potassium | Losartan Potassium | 94 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 93 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 90 | suppressed |
| Famotidine | Famotidine | 88 | 12 |
| Omeprazole | Omeprazole | 84 | 13 |
| Carvedilol | Carvedilol | 83 | suppressed |
| Memantine Hcl | Memantine Hcl | 83 | suppressed |
| Trulicity | Dulaglutide | 74 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 22 |
| Mirtazapine | Mirtazapine | 69 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 65 | suppressed |
| Ezetimibe | Ezetimibe | 64 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 63 | suppressed |
| Prolia | Denosumab | 63 | 36 |
| Tramadol Hcl | Tramadol Hcl | 60 | 20 |
| Risperidone | Risperidone | 56 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 55 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 55 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | suppressed |
| Topiramate | Topiramate | 54 | suppressed |
| Bupropion Xl | Bupropion Hcl | 53 | suppressed |
| Meloxicam | Meloxicam | 53 | suppressed |
| Aripiprazole | Aripiprazole | 52 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 48 | suppressed |
| Glipizide | Glipizide | 46 | suppressed |
| Ranolazine Er | Ranolazine | 46 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 40 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | suppressed |
| Latanoprost | Latanoprost | 37 | suppressed |
| Finasteride | Finasteride | 35 | suppressed |
| Baclofen | Baclofen | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 34 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 32 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 32 | suppressed |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 30 | 14 |
| Linzess | Linaclotide | 28 | suppressed |
| Jantoven | Warfarin Sodium | 27 | suppressed |
| Lacosamide | Lacosamide | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 25 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Alprazolam Er | Alprazolam | 22 | suppressed |
| Azathioprine | Azathioprine | 22 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Nystatin | Nystatin | 22 | 12 |
| Primidone | Primidone | 22 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Prednisone | Prednisone | 20 | 11 |
| Azithromycin | Azithromycin | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Calcitriol | Calcitriol | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 14 |
| Nitroglycerin | Nitroglycerin | 18 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Fluconazole | Fluconazole | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 16 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 14 |
| Victoza 3-Pak | Liraglutide | 15 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Alogliptin | Alogliptin Benzoate | 13 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 13 | suppressed |
| Ethambutol Hcl | Ethambutol Hcl | 13 | suppressed |
| Etodolac | Etodolac | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Minoxidil | Minoxidil | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Rayaldee | Calcifediol | 13 | suppressed |
| Rezvoglar Kwikpen | Insulin Glargine-Aglr | 13 | suppressed |
| Rifampin | Rifampin | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Trexall | Methotrexate Sodium | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Exemestane | Exemestane | 12 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Ofloxacin | Ofloxacin | 12 | suppressed |
| Pramipexole Er | Pramipexole Di-Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.11 · 1 records | Braeburn Inc. | BRIXADI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error